|
Axion Biosystems has developed the next generation multi-electrode array (MEA) technology to provide unprecedented access to cellular information at a reasonable cost. Axion Biosystems' proprietary technology addresses two challenges that have existed in the cellular analysis field. First, we have eliminated the long-lasting stimulation artifacts from the electrophysiological tissue response, enabling simultaneous stimulation and recording. Second, we have created fabrication methods for low-cost microelectrode arrays. The combination of these developments allows for high throughput cell-based assays and superior electro-active tissue diagnostics. |
|